146 related articles for article (PubMed ID: 7913478)
1. Trends in the residential (inpatient) treatment of individuals with a dual diagnosis.
Spreat S; Behar D
J Consult Clin Psychol; 1994 Feb; 62(1):43-8. PubMed ID: 7913478
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic drug use with successful and unsuccessful community placed developmentally disabled groups.
Harder SR; Kalachnik JE; Jensen MA; Feltz J
Res Dev Disabil; 1987; 8(2):191-202. PubMed ID: 2890188
[TBL] [Abstract][Full Text] [Related]
3. Current status of the Matson Evaluation of Drug Side Effects (MEDS).
Matson JL; Cervantes PE
Res Dev Disabil; 2013 May; 34(5):1849-53. PubMed ID: 23528442
[TBL] [Abstract][Full Text] [Related]
4. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment considerations with comorbid developmentally disabled populations.
Fuller CG; Sabatino DA
J Clin Psychol; 1998 Jan; 54(1):1-10. PubMed ID: 9476703
[TBL] [Abstract][Full Text] [Related]
6. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
Lunsky Y; Modi M
Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
[TBL] [Abstract][Full Text] [Related]
8. Trends in mental health services for people with intellectual disability in residential care in Israel 1998-2004.
Merrick J; Kandel I; Stawski M
Isr J Psychiatry Relat Sci; 2006; 43(4):281-4. PubMed ID: 17338448
[TBL] [Abstract][Full Text] [Related]
9. Measurement of problem behaviour during medication evaluations.
Zarcone J; Napolitano D; Valdovinos M
J Intellect Disabil Res; 2008 Dec; 52(12):1015-28. PubMed ID: 18717764
[TBL] [Abstract][Full Text] [Related]
10. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
11. [Psychotropic drug prescription to people with intellectual disability in GP practices].
Bakker-van Gijssel EJ; Leusink GL
Ned Tijdschr Geneeskd; 2015; 159():A9754. PubMed ID: 26629605
[TBL] [Abstract][Full Text] [Related]
12. A review of empirical evidence of somatic treatment options for the MI/DD population.
Ulzen TP; Powers RE
Psychiatr Q; 2008 Sep; 79(3):265-73. PubMed ID: 18726159
[TBL] [Abstract][Full Text] [Related]
13. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services.
Paton C; Flynn A; Shingleton-Smith A; McIntyre S; Bhaumik S; Rasmussen J; Hardy S; Barnes T
J Intellect Disabil Res; 2011 Jul; 55(7):665-74. PubMed ID: 21507097
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
15. Frequency of and determinants for psychotropic drug use in an institution for the mentally retarded.
Linaker OM
Br J Psychiatry; 1990 Apr; 156():525-30. PubMed ID: 1974820
[TBL] [Abstract][Full Text] [Related]
16. From inpatient to inn status. A new residential model.
Gudeman JE; Dickey B; Hellman S; Buffett W
Psychiatr Clin North Am; 1985 Sep; 8(3):461-9. PubMed ID: 4059089
[TBL] [Abstract][Full Text] [Related]
17. Treatment of psychiatric morbidity in the mentally retarded adult.
Lund J
Acta Psychiatr Scand; 1986 Apr; 73(4):429-36. PubMed ID: 2873716
[TBL] [Abstract][Full Text] [Related]
18. Community-based behavioral training approaches for people with mental retardation and mental illness.
Petronko MR; Harris SL; Kormann RJ
J Consult Clin Psychol; 1994 Feb; 62(1):49-54. PubMed ID: 8034828
[TBL] [Abstract][Full Text] [Related]
19. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
[TBL] [Abstract][Full Text] [Related]
20. Safety of antipsychotics in people with intellectual disability.
Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
